مرکز منطقه ای اطلاع رساني علوم و فناوري - Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Title of article :

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

Author/Authors :

Ludwig Kappos، نويسنده , , Mark S. Freedman، نويسنده , , Chris H. Polman، نويسنده , , Gilles Edan، نويسنده , , Hans-Peter Hartung، نويسنده , , David H Miller، نويسنده , , Xavier Montalban، نويسنده , , Frederik Barkhof، نويسنده , , Ernst-Wilhelm Radü، نويسنده , , Lars Bauer، نويسنده , , Susanne Dahms، نويسنده , , Vivian Lanius، نويسنده , , Christoph Pohl، نويسنده , , Rupert Sandbrink، نويسنده ,

Issue Information :

روزنامه با شماره پیاپی سال 2008

Pages :

From page :

389

To page :

397

Abstract :

Background Several controlled studies provide evidence that treatment with interferon beta in patients with a first event suggestive of multiple sclerosis (MS) delays conversion to clinically definite MS (CDMS). Our aim was to determine whether early init

Journal title :

The Lancet

Serial Year :

2008

Journal title :

The Lancet

Record number :

591717

Link To Document :

https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=591717